Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial

Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the page.
    Difference
    0.0%
    Check dated 2026-03-11T17:48:53.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the earlier notices about government funding interruptions and operating status (Revision: v3.4.1).
    Difference
    0.3%
    Check dated 2026-02-11T11:00:39.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government-funding lapse notice at the top of the page. Updated the site to revision v3.4.1, replacing v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T06:22:24.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added UI/metadata updates: a 'Show glossary' toggle, the QC label 'Last Update Submitted that Met QC Criteria', the 'No FEAR Act Data' notice, and the revision tag 'Revision: v3.4.0' (replacing the older lowercase label, 'No FEAR Act data', and 'Revision: v3.3.4').
    Difference
    0.1%
    Check dated 2026-01-28T04:24:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision notice updated from Revision: v3.3.3 to Revision: v3.3.4. No study content or navigation elements were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:52:29.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section updated with new sites across Alabama, Arkansas, California, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, New Jersey, New York, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, and Milano. The page revision is bumped to v3.3.3, with removal of older Milano Locations and the HHS Vulnerability Disclosure notice.
    Difference
    2%
    Check dated 2025-12-23T08:33:46.000Z thumbnail image

Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.